Report from the Neurological Alliance Calls for Improvements for Rare Neurological Disease Patients
kreatikar / Pixabay

Report from the Neurological Alliance Calls for Improvements for Rare Neurological Disease Patients

The Neurological Alliance has released a report that details the experiences that rare, neurological disease patients in the UK share and calls for improvements for these people. Experts in the…

Continue Reading Report from the Neurological Alliance Calls for Improvements for Rare Neurological Disease Patients

A CRISPR Tool With the Potential to Halt the Progression of Sickle Cell and Beta Thalassemia

According to an NBC AP news item, early results show that CRISPR, a “tool” that alters DNA permanently in blood cells, has the potential to not only stop the progression…

Continue Reading A CRISPR Tool With the Potential to Halt the Progression of Sickle Cell and Beta Thalassemia
The N-Lorem Foundation is Developing Treatments for Patients With Ultra-Rare Diseases
source: pixabay.com

The N-Lorem Foundation is Developing Treatments for Patients With Ultra-Rare Diseases

  A recent article in the Encinitas Advocate heralded the dedication of Stan Crooke, n-Lorem Foundation’s CEO and founder. The nonprofit Foundation’s team acts as middlemen, working with patients who…

Continue Reading The N-Lorem Foundation is Developing Treatments for Patients With Ultra-Rare Diseases
Artificial Intelligence Could Improve Drug Development, But it Faces Obstacles
https://pixabay.com/en/technology-robot-human-hand-2025795/

Artificial Intelligence Could Improve Drug Development, But it Faces Obstacles

Many medical professionals have applauded artificial intelligence and machine learning in the drug development process for a long time, as they can increase the speed while decreasing the cost. However,…

Continue Reading Artificial Intelligence Could Improve Drug Development, But it Faces Obstacles
Avoid These 5 Real-World Data Pitfalls When Planning your Patient Registry, Natural History, or Other Clinical Study for a Rare Disease
source: pixabay.com

Avoid These 5 Real-World Data Pitfalls When Planning your Patient Registry, Natural History, or Other Clinical Study for a Rare Disease

Author: Harsha K Rajasimha, MS, Ph.D. Editor: Sharlene Brown, Ph.D. When clinical investigators and study coordinators start planning a new study design, speed and efficiency are paramount. Running a clinical…

Continue Reading Avoid These 5 Real-World Data Pitfalls When Planning your Patient Registry, Natural History, or Other Clinical Study for a Rare Disease